Investing.com -- US stock futures steadied Tuesday, with investors reluctant to chase the market too much higher after Donald Trump’s threatened a global trade war once he gets into office.
Here are some of the biggest premarket US stock movers today: Kohl’s (NYSE:KSS ) stock slumped 12% after the retailer cut its annual sales forecast for the third time this year, in a sign the department-store chain is struggling to draw in shoppers ahead of a deal-heavy holiday shopping season. Best Buy (NYSE:BBY ) stock fell 7.4% after the electronics retailer cut its full-year sales forecast as it missed quarterly revenue expectations due to softer demand. Dick’s Sporting Goods (NYSE:DKS ) stock rose 6.4% after the retailer raised its full-year guidance after what CEO Lauren Hobart called an "excellent" back-to-school shopping season and better-than-expected comparable sales for its third quarter. Ford (NYSE:F ) stock fell 1.8% and General Motors (NYSE:GM ) stock dropped 3.8% as investors shunned the auto giants in the wake of Trump’s tariff comments as they have highly integrated supply chains across Mexico, the US and Canada. Novo Nordisk (NYSE:NVO ) stock rose 2.2%, with the weight-loss drug maker benefitting from President Joe Biden proposing expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid. Burlington Stores (NYSE:BURL ) stock fell 5.4% after the department store retailer’s fourth-quarter forecast for earnings and comparable sales growth missed expectations. Rumble (NASDAQ:RUM ) stock rose 3% after the video platform said it will begin allocating a portion of its excess cash reserves to bitcoin, making purchases of up to $20 million in the cryptocurrency. Intel (NASDAQ:INTC ) stock rose 1.2% after the US Commerce Department said it was finalizing a $7.86 billion government subsidy for the tech giant, down from the $8.5 billion announced in March after the California-based chips maker won a separate $3 billion award from the Pentagon. Poseida Therapeutics (NASDAQ:PSTX ) stock soared over 200% after Switzerland's Roche said it will acquire the cell therapy maker in a cash deal worth up to $1.5 billion. Analog Devices (NASDAQ:ADI ) stock rose 5.6% after the semiconductor reported a profit for the fourth quarter that decreased from the same period last year but beat the Street estimates.
Source: Investing.com